211 related articles for article (PubMed ID: 27334845)
21. DHCR7 links cholesterol synthesis with neuronal development and axonal integrity.
Miyazaki S; Shimizu N; Miyahara H; Teranishi H; Umeda R; Yano S; Shimada T; Shiraishi H; Komiya K; Katoh A; Yoshimura A; Hanada R; Hanada T
Biochem Biophys Res Commun; 2024 Jun; 712-713():149932. PubMed ID: 38626530
[TBL] [Abstract][Full Text] [Related]
22. Late gestational lung hypoplasia in a mouse model of the Smith-Lemli-Opitz syndrome.
Yu H; Wessels A; Chen J; Phelps AL; Oatis J; Tint GS; Patel SB
BMC Dev Biol; 2004 Feb; 4():1. PubMed ID: 15005800
[TBL] [Abstract][Full Text] [Related]
23. No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome.
Roullet JB; Merkens LS; Pappu AS; Jacobs MD; Winter R; Connor WE; Steiner RD
J Inherit Metab Dis; 2012 Sep; 35(5):859-69. PubMed ID: 22391996
[TBL] [Abstract][Full Text] [Related]
24. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management.
Porter FD
Eur J Hum Genet; 2008 May; 16(5):535-41. PubMed ID: 18285838
[TBL] [Abstract][Full Text] [Related]
25. A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome.
Tulenko TN; Boeze-Battaglia K; Mason RP; Tint GS; Steiner RD; Connor WE; Labelle EF
J Lipid Res; 2006 Jan; 47(1):134-43. PubMed ID: 16258167
[TBL] [Abstract][Full Text] [Related]
26. DHCR7: A vital enzyme switch between cholesterol and vitamin D production.
Prabhu AV; Luu W; Li D; Sharpe LJ; Brown AJ
Prog Lipid Res; 2016 Oct; 64():138-151. PubMed ID: 27697512
[TBL] [Abstract][Full Text] [Related]
27. The p.Phe174Ser mutation is associated with mild forms of Smith Lemli Opitz Syndrome.
Tucci A; Ronzoni L; Arduino C; Salmin P; Esposito S; Milani D
BMC Med Genet; 2016 Mar; 17():22. PubMed ID: 26969503
[TBL] [Abstract][Full Text] [Related]
28. The Smith-Lemli-Opitz syndrome and dentofacial anomalies diagnostic: Case reports and literature review.
Rojare C; Opdenakker Y; Laborde A; Nicot R; Mention K; Ferri J
Int Orthod; 2019 Jun; 17(2):375-383. PubMed ID: 31005410
[TBL] [Abstract][Full Text] [Related]
29. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.
Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y
J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653
[TBL] [Abstract][Full Text] [Related]
30. Precholesterol sterols accumulate in lipid rafts of patients with Smith-Lemli-Opitz syndrome and X-linked dominant chondrodysplasia punctata.
Rakheja D; Boriack RL
Pediatr Dev Pathol; 2008; 11(2):128-32. PubMed ID: 17378665
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical and microarray analyses of a mouse model for the smith-lemli-opitz syndrome.
Waage-Baudet H; Dunty WC; Dehart DB; Hiller S; Sulik KK
Dev Neurosci; 2005; 27(6):378-96. PubMed ID: 16280635
[TBL] [Abstract][Full Text] [Related]
32. The Actin Cytoskeleton Is Involved in Glial Cell Line-Derived Neurotrophic Factor (GDNF)-Induced Ret Translocation into Lipid Rafts in Dopaminergic Neuronal Cells.
Li L; Song H; Mu P; Xu M; Liu C; Wang Y; Qin Y; Sun S; Gao J; Wang T; Gao D
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28880247
[TBL] [Abstract][Full Text] [Related]
33. Smith-Lemli-Opitz syndrome: the first malformation syndrome associated with defective cholesterol synthesis.
Battaile KP; Steiner RD
Mol Genet Metab; 2000; 71(1-2):154-62. PubMed ID: 11001806
[TBL] [Abstract][Full Text] [Related]
34. Analysis by liquid chromatography-mass spectrometry of sterols and oxysterols in brain of the newborn Dhcr7(Δ3-5/T93M) mouse: a model of Smith-Lemli-Opitz syndrome.
Meljon A; Watson GL; Wang Y; Shackleton CH; Griffiths WJ
Biochem Pharmacol; 2013 Jul; 86(1):43-55. PubMed ID: 23500538
[TBL] [Abstract][Full Text] [Related]
35. Probes for protein adduction in cholesterol biosynthesis disorders: Alkynyl lanosterol as a viable sterol precursor.
Tallman KA; Kim HH; Korade Z; Genaro-Mattos TC; Wages PA; Liu W; Porter NA
Redox Biol; 2017 Aug; 12():182-190. PubMed ID: 28258022
[TBL] [Abstract][Full Text] [Related]
36. Signaling by the human serotonin(1A) receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome.
Paila YD; Murty MR; Vairamani M; Chattopadhyay A
Biochim Biophys Acta; 2008 Jun; 1778(6):1508-16. PubMed ID: 18381059
[TBL] [Abstract][Full Text] [Related]
37. Alterations in membrane caveolae and BKCa channel activity in skin fibroblasts in Smith-Lemli-Opitz syndrome.
Ren G; Jacob RF; Kaulin Y; Dimuzio P; Xie Y; Mason RP; Tint GS; Steiner RD; Roullet JB; Merkens L; Whitaker-Menezes D; Frank PG; Lisanti MP; Cox RH; Tulenko TN
Mol Genet Metab; 2011 Nov; 104(3):346-55. PubMed ID: 21724437
[TBL] [Abstract][Full Text] [Related]
38. Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome.
Xu L; Liu W; Sheflin LG; Fliesler SJ; Porter NA
J Lipid Res; 2011 Oct; 52(10):1810-20. PubMed ID: 21817059
[TBL] [Abstract][Full Text] [Related]
39. Behavioral and serotonergic response changes in the Dhcr7-HET mouse model of Smith-Lemli-Opitz syndrome.
Korade Z; Folkes OM; Harrison FE
Pharmacol Biochem Behav; 2013 May; 106():101-8. PubMed ID: 23541496
[TBL] [Abstract][Full Text] [Related]
40. Cholesterol storage defect in RSH/Smith-Lemli-Opitz syndrome fibroblasts.
Wassif CA; Vied D; Tsokos M; Connor WE; Steiner RD; Porter FD
Mol Genet Metab; 2002 Apr; 75(4):325-34. PubMed ID: 12051964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
